| General Information | |||
|---|---|---|---|
| Term | lymphangioleiomyomatosis | ID (Ontology) | DOID:3319 (Human Disease) |
| Definition | A lung disease that is characterized by progressive cystic destruction of the lung and lymphatic abnormalities, frequently associated with renal angiomyolipomas. | ||
| Also Known As | "lung lymphangioleiomyomatosis" ; "lymphangiomyomatosis" ; "pulmonary lymphangioleiomyomatosis" | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
lower respiratory tract disease |__lung disease |__lymphangioleiomyomatosis 2 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | lung disease | ||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:3319 ICDO:9174/1 MIM:606690 NCI:C38153 ORDO:538 SNOMEDCT_US_2023_03_01:277844007 UMLS_CUI:C0349649 |
|||